JP2015519403A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519403A5
JP2015519403A5 JP2015517461A JP2015517461A JP2015519403A5 JP 2015519403 A5 JP2015519403 A5 JP 2015519403A5 JP 2015517461 A JP2015517461 A JP 2015517461A JP 2015517461 A JP2015517461 A JP 2015517461A JP 2015519403 A5 JP2015519403 A5 JP 2015519403A5
Authority
JP
Japan
Prior art keywords
region
controlled release
mucosa
release polymer
mucoadhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015517461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015519403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/045976 external-priority patent/WO2013188819A2/en
Publication of JP2015519403A publication Critical patent/JP2015519403A/ja
Publication of JP2015519403A5 publication Critical patent/JP2015519403A5/ja
Pending legal-status Critical Current

Links

JP2015517461A 2012-06-14 2013-06-14 活性剤送達のための粘膜付着性デバイス Pending JP2015519403A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261659784P 2012-06-14 2012-06-14
US201261659781P 2012-06-14 2012-06-14
US61/659,784 2012-06-14
US61/659,781 2012-06-14
US201261671287P 2012-07-13 2012-07-13
US61/671,287 2012-07-13
PCT/US2013/045976 WO2013188819A2 (en) 2012-06-14 2013-06-14 Mucoadhesive devices for delivery of active agents

Publications (2)

Publication Number Publication Date
JP2015519403A JP2015519403A (ja) 2015-07-09
JP2015519403A5 true JP2015519403A5 (enExample) 2016-07-14

Family

ID=48748504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517461A Pending JP2015519403A (ja) 2012-06-14 2013-06-14 活性剤送達のための粘膜付着性デバイス

Country Status (5)

Country Link
US (4) US20150174076A1 (enExample)
EP (1) EP2861220A2 (enExample)
JP (1) JP2015519403A (enExample)
CA (1) CA2915358A1 (enExample)
WO (1) WO2013188819A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107072950B (zh) * 2014-09-11 2020-11-03 嘉利达股份有限公司 明胶/果胶粒子
ES2630106T3 (es) 2014-10-07 2017-08-18 Cyprumed Gmbh Formulaciones farmacéuticas para la administración oral de fármacos peptídicos o proteicos
EP3359181A1 (en) 2015-10-07 2018-08-15 Cyprumed GmbH Pharmaceutical formulations for the oral delivery of peptide drugs
CA3012698A1 (en) * 2016-02-05 2017-08-10 Entrega Inc. Oral dosage form with drying agent for delivery of active agent
WO2017143294A1 (en) 2016-02-18 2017-08-24 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
WO2018065634A1 (en) 2016-10-07 2018-04-12 Cyprumed Gmbh Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
MX382197B (es) 2017-01-23 2025-03-13 Afyx Therapeutics As Metodo para la fabricacion de un producto de dos capas basado en fibras electrohiladas.
US20180235899A1 (en) * 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
WO2018213600A1 (en) 2017-05-17 2018-11-22 Massachusetts Institute Of Technology Self-righting systems and related components and methods
JP7260913B2 (ja) * 2017-06-27 2023-04-19 株式会社バイオセレンタック 粘膜付着性経口製剤
EP3773475A1 (en) 2018-04-06 2021-02-17 Cyprumed GmbH Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
WO2019222570A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
EP3917598B1 (en) 2019-02-01 2025-10-29 Massachusetts Institute of Technology Systems for liquid injection
WO2021030474A1 (en) 2019-08-12 2021-02-18 Massachusetts Institute Of Technology Articles and methods for administration of therapeutic agents
US11793980B2 (en) 2019-08-31 2023-10-24 Celero Systems, Inc. Intestinal attachment device
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components
JP2023541827A (ja) 2020-09-07 2023-10-04 サイプルメド ゲーエムベーハー Ｇｌｐ－１受容体アゴニストの改善された医薬製剤
AU2022241157A1 (en) * 2021-03-15 2023-09-07 Epitomee Medical Ltd. Expandable devices for delivery of active agents to tissues
EP4486366A1 (en) 2022-03-03 2025-01-08 Cyprumed GmbH Improved oral pharmaceutical formulations of therapeutic peptides and proteins
AU2023346631A1 (en) 2022-09-21 2025-05-01 Epitomee Medical Ltd. Controllably disintegrable self-expandable ingestible devices

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US6159497A (en) * 1998-10-30 2000-12-12 Noven Pharmaceuticals, Inc. Patch applicator
WO2003007913A2 (en) * 2001-07-20 2003-01-30 Samir Mitragotri Method for oral drug delivery
KR20040091014A (ko) * 2002-02-07 2004-10-27 위스콘신 얼럼나이 리서어치 화운데이션 항암 요법과 병행해서 사용하기 위한 폴리아민 화합물 및조성물
EP2444069B1 (en) * 2003-07-23 2019-06-05 Evonik Corporation Controlled release compositions
JP5586151B2 (ja) * 2005-12-13 2014-09-10 バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド 乱用抵抗性経粘膜薬剤送達デバイス
BRPI0711168A2 (pt) * 2006-05-02 2011-08-23 Panacea Biotec Ltd composição transmucosal
JP5005422B2 (ja) * 2007-05-09 2012-08-22 株式会社エンプラス 射出成形ギヤ
CA2817982C (en) * 2010-11-15 2020-06-30 The Regents Of The University Of Michigan Controlled release mucoadhesive systems
JP6139506B2 (ja) * 2011-04-04 2017-05-31 コロプラスト アクティーゼルスカブ 接着パッチ

Similar Documents

Publication Publication Date Title
JP2015519403A5 (enExample)
HK1219096A1 (zh) 抗篡改的药物制剂
AR090218A1 (es) Formulaciones de liberacion inmediata resistentes a la manipulacion
MX2014011626A (es) Peliculas de capas multiples capaces de liberar ingredientes activos por un periodo limitado de tiempo.
RU2700926C2 (ru) Трансдермальные системы, предотвращающие злоупотребление и неправильное употребление
WO2014102613A3 (en) Device for disposal and neutralization of pharmaceutical agents
AR073704A1 (es) Sistema de administracion transdermal de droga para principios activos liquidos que tiene una capa de matriz adhesiva que incluye un ingrediente farmaceutico activo que es seleccionado entre selegilina y rivastigmina
JP2012085643A5 (enExample)
CN110035744A (zh) 一种尼拉帕尼缓控释药物组合物及其用途
JP2014528431A5 (enExample)
PE20190105A1 (es) Formas de dosificacion de liberacion modificada disuasivas de abuso
PE20142035A1 (es) Formulacion compuesta que comprende un comprimido esferoidal de multiples unidades (must) encapsulada en una capsula dura y metodo para preparar la misma
WO2006023286A3 (en) Controlled release nanoparticle active agent formulation dosage forms and methods
CO6400184A2 (es) Formulaciones galénicas de compuestos orgánicos
EP3556369A4 (en) PROLONGED-RELEASE ORAL PHARMACEUTICAL COMPOSITION OF OLAPARIB AND USES THEREOF
CR20150077A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
JP2014526519A5 (enExample)
WO2014130553A3 (en) Tablet dosage form comprising ritonavir and lopinavir
JP2014514104A5 (enExample)
JP2015508411A5 (enExample)
WO2015107544A3 (en) Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
WO2012092486A3 (en) Modified release benzimidazole formulations
WO2017123315A3 (en) Nanocrystals formed in a microenvironment
RU2007136310A (ru) Способ получения наноразмерной системы доставки лекарственных средств на основе диоксида кремния
ES2606399T3 (es) Formulación sólida de liberación controlada para administración oral en un sobre de dosis única y método de preparación de la misma